Nantahala Capital Management LLC 13D and 13G filings for Fortress Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management LLC | 372,562 4.200% |
-158,642 (-29.86%) |
Filing |
| 2023-02-14 5:01 pm Sale |
2022-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management LLC | 531,204 7.300% |
-74,530 (-12.30%) |
Filing |
| 2022-02-14 08:13 am Purchase |
2021-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management LLC | 605,734 9.600% |
27,006 (+4.67%) |
Filing |
| 2021-02-16 06:23 am Purchase |
2020-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management LLC | 578,727 9.300% |
578,727 (New Position) |
Filing |